0001062993-23-019700.txt : 20231025
0001062993-23-019700.hdr.sgml : 20231025
20231025163044
ACCESSION NUMBER: 0001062993-23-019700
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231023
FILED AS OF DATE: 20231025
DATE AS OF CHANGE: 20231025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Frieberg Jacob B.
CENTRAL INDEX KEY: 0001748346
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38624
FILM NUMBER: 231346398
MAIL ADDRESS:
STREET 1: 1895 MOUNT HOPE AVENUE
CITY: ROCHESTER
STATE: NY
ZIP: 14620
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VACCINEX, INC.
CENTRAL INDEX KEY: 0001205922
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 161603202
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1895 MOUNT HOPE AVE
CITY: ROCHESTER
STATE: NY
ZIP: 14620
BUSINESS PHONE: 585-271-2700
MAIL ADDRESS:
STREET 1: 1895 MOUNT HOPE AVE
CITY: ROCHESTER
STATE: NY
ZIP: 14620
FORMER COMPANY:
FORMER CONFORMED NAME: VACCINEX INC
DATE OF NAME CHANGE: 20021114
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-10-23
0001205922
VACCINEX, INC.
VCNX
0001748346
Frieberg Jacob B.
C/O VACCINEX, INC.
1895 MOUNT HOPE AVENUE
ROCHESTER
NY
14620
1
0
0
0
0
Common Stock
4235
D
Common Stock
6301
I
By Benbow Estates, Ltd.
Common Stock
12870
I
By Gee Eff Services Limited
Stock Option (Right to Buy)
204.0
2027-09-15
Common Stock
426
426
D
Stock Option (Right to Buy)
78.9
2029-03-30
Common Stock
166
166
D
Stock Option (Right to Buy)
116.7
Common Stock
514
514
D
Stock Option (Right to Buy)
82.8
2029-06-29
Common Stock
159
159
D
Stock Option (Right to Buy)
107.55
2029-09-27
Common Stock
123
123
D
Stock Option (Right to Buy)
72.75
2029-12-28
Common Stock
182
182
D
Stock Option (Right to Buy)
60.0
2030-03-29
Common Stock
222
222
D
Stock Option (Right to Buy)
59.25
Common Stock
1045
1045
D
Stock Option (Right to Buy)
54.15
2030-06-28
Common Stock
250
250
D
Stock Option (Right to Buy)
26.7
2030-09-28
Common Stock
508
508
D
Stock Option (Right to Buy)
31.05
2030-12-29
Common Stock
436
436
D
Stock Option (Right to Buy)
44.7
2031-03-31
Common Stock
302
302
D
Stock Option (Right to Buy)
32.25
Common Stock
1905
1905
D
Stock Option (Right to Buy)
42.0
2031-06-28
Common Stock
320
320
D
Stock Option (Right to Buy)
32.4
2031-09-28
Common Stock
415
415
D
Stock Option (Right to Buy)
15.6
2031-12-29
Common Stock
857
857
D
Stock Option (Right to Buy)
19.8
2032-03-28
Common Stock
668
668
D
Stock Option (Right to Buy)
16.8
Common Stock
3550
3550
D
Stock Option (Right to Buy)
16.2
2032-06-27
Common Stock
804
804
D
Stock Option (Right to Buy)
7.43
2032-09-27
Common Stock
1750
1750
D
Stock Option (Right to Buy)
9.68
2032-12-28
Common Stock
1323
1323
D
Stock Option (Right to Buy)
5.99
2033-03-28
Common Stock
2140
2140
D
Stock Option (Right to Buy)
6.15
2024-05-11
Common Stock
9589
9589
D
Stock Option (Right to Buy)
5.34
2033-06-27
Common Stock
2414
2414
D
Stock Option (Right to Buy)
1.13
2023-10-23
4
D
0
11291
0.77
D
2023-09-29
2033-09-26
Common Stock
11291
0
D
Mr. Frieberg's spouse is the owner of Benbow Estates, Ltd. and Mr. Frieberg is an officer of Benbow Estates, Ltd. Mr. Frieberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Mr. Frieberg is the sole owner and President of Gee Eff Services Limited.
Exercisable in full as of the date of this report.
This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.
This option expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first.
This option was canceled by mutual agreement of the reporting person and Vaccinex, Inc. The reporting person received $8,750 as consideration for the cancellation, which represents the reporting person's retainer and meeting fees during the third quarter of 2023.
On September 25, 2023, Vaccinex, Inc. effected a 1-for-15 reverse stock split (the "Reverse Stock Split"). The number of stock options and underlying shares of common stock in this Form 4 reflect the Reverse Stock Split.
/s/ Scott E. Royer, Attorney-in-Fact for Jacob B. Frieberg
2023-10-25